SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

--BMO Capital Adjusts Price Target on Travere Therapeutics to $38 From $43, Keeps Outperform Rating

05/07/2021 10:04

01:58 PM EDT, 05/07/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 20.79, Change: -2.71, Percent Change: -11.53